Aspire BioPharma is trading at $6.03 (+7.49%) in after-hours trading following a sharp selloff during the regular session.
- No company-specific catalysts, such as earnings releases or FDA updates, have been identified to account for the move.
- The price action appears consistent with thin extended-hours liquidity and a broader risk-off market environment, as U.S. indexes and futures remained weaker on July 29.